Zepp Health Corporation (ZEPP)
NYSE: ZEPP · Real-Time Price · USD
2.550
-0.140 (-5.20%)
At close: Jun 27, 2025, 4:00 PM
2.570
+0.020 (0.78%)
After-hours: Jun 27, 2025, 7:00 PM EDT
Zepp Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 181.18 | 182.6 | 352.86 | 613.64 | 983.87 | 985.41 | Upgrade
|
| Revenue Growth (YoY) | -38.79% | -48.25% | -42.50% | -37.63% | -0.16% | 18.05% | Upgrade
|
| Cost of Revenue | 111.29 | 112.37 | 260.5 | 494.78 | 778.34 | 781.29 | Upgrade
|
| Gross Profit | 69.9 | 70.23 | 92.36 | 118.86 | 205.53 | 204.13 | Upgrade
|
| Selling, General & Admin | 74.5 | 71.33 | 71.31 | 103.42 | 109.66 | 95.04 | Upgrade
|
| Research & Development | 45.12 | 46.16 | 51.5 | 77.3 | 81.08 | 82.41 | Upgrade
|
| Operating Expenses | 119.61 | 117.48 | 122.81 | 180.71 | 190.74 | 177.45 | Upgrade
|
| Operating Income | -49.72 | -47.25 | -30.45 | -61.86 | 14.79 | 26.68 | Upgrade
|
| Interest Expense | -5.47 | -5.55 | -6.75 | -8.44 | -7.07 | -3.47 | Upgrade
|
| Interest & Investment Income | 3.24 | 3.67 | 3.09 | 1.82 | 2.63 | 7.06 | Upgrade
|
| Earnings From Equity Investments | -4.01 | -4.21 | 1.11 | 2.68 | 6.46 | -0.73 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.72 | -0.66 | -0.53 | 6.45 | 4.32 | -0.14 | Upgrade
|
| EBT Excluding Unusual Items | -56.67 | -54 | -33.53 | -59.35 | 21.12 | 29.41 | Upgrade
|
| Gain (Loss) on Sale of Investments | -10.35 | -8.12 | 0.01 | 6.14 | 2.13 | 1.89 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | - | - | 8.66 | Upgrade
|
| Pretax Income | -67.02 | -62.12 | -33.52 | -53.21 | 23.25 | 39.96 | Upgrade
|
| Income Tax Expense | 13.73 | 13.69 | -2.43 | -9.87 | 1.69 | 4.77 | Upgrade
|
| Earnings From Continuing Operations | -80.75 | -75.81 | -31.09 | -43.35 | 21.56 | 35.18 | Upgrade
|
| Minority Interest in Earnings | 0.04 | 0.08 | 0.07 | 0.1 | 0.13 | -0.15 | Upgrade
|
| Net Income | -80.71 | -75.73 | -31.02 | -43.24 | 21.69 | 35.04 | Upgrade
|
| Net Income to Common | -80.71 | -75.73 | -31.02 | -43.24 | 21.69 | 35.04 | Upgrade
|
| Net Income Growth | - | - | - | - | -38.09% | -57.58% | Upgrade
|
| Shares Outstanding (Basic) | 16 | 16 | 15 | 15 | 16 | 16 | Upgrade
|
| Shares Outstanding (Diluted) | 16 | 16 | 15 | 15 | 17 | 16 | Upgrade
|
| Shares Change (YoY) | 4.61% | 6.47% | -1.28% | -6.84% | 1.54% | 1.72% | Upgrade
|
| EPS (Basic) | -5.00 | -4.68 | -2.04 | -2.81 | 1.38 | 2.26 | Upgrade
|
| EPS (Diluted) | -5.00 | -4.68 | -2.08 | -2.88 | 1.31 | 2.16 | Upgrade
|
| EPS Growth | - | - | - | - | -39.27% | -58.10% | Upgrade
|
| Free Cash Flow | - | -25.8 | 41.01 | -118.32 | -43.84 | 11.3 | Upgrade
|
| Free Cash Flow Per Share | - | -1.59 | 2.70 | -7.69 | -2.65 | 0.69 | Upgrade
|
| Gross Margin | 38.58% | 38.46% | 26.17% | 19.37% | 20.89% | 20.71% | Upgrade
|
| Operating Margin | -27.44% | -25.88% | -8.63% | -10.08% | 1.50% | 2.71% | Upgrade
|
| Profit Margin | -44.54% | -41.47% | -8.79% | -7.05% | 2.21% | 3.56% | Upgrade
|
| Free Cash Flow Margin | - | -14.13% | 11.62% | -19.28% | -4.46% | 1.15% | Upgrade
|
| EBITDA | -45.37 | -42.23 | -22.76 | -53.15 | 22.96 | 30.84 | Upgrade
|
| EBITDA Margin | -25.04% | -23.13% | -6.45% | -8.66% | 2.33% | 3.13% | Upgrade
|
| D&A For EBITDA | 4.35 | 5.02 | 7.69 | 8.71 | 8.17 | 4.16 | Upgrade
|
| EBIT | -49.72 | -47.25 | -30.45 | -61.86 | 14.79 | 26.68 | Upgrade
|
| EBIT Margin | -27.44% | -25.88% | -8.63% | -10.08% | 1.50% | 2.71% | Upgrade
|
| Effective Tax Rate | - | - | - | - | 7.27% | 11.94% | Upgrade
|
Updated Apr 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.